Member Info for Diversified

That reaction says just about all you need to know what happens to this share price on positive phase iii results.

44p for starters and on decent volume this will pop imo!

Has a US listing ever been discussed with the board?

Imo following phase III results the FDA approval should be a formality, as stated by an analyst from SP Angel. With the derisked proposition then being priced in between positive results and approval this imo should have no problem in reaching 100p+ over time.

Positive phase III results and a share price of anything less then 70p in the short term is a great opportunity to continue buying more.

To consider the current market cap. and investment to date, with Phase III results highly probable to meet its endpoint. Even at its current valuation following a run in the share price this remains seriously under the radar and good value.

I have been invested for a relatively short period of time but occasionally you come across a company that fills you with excitement and ticks every box.

With the current share price restrained by a rotation of stock caused by a distressed seller, I believe the current share price continues to present value. My expectation is for this share price to follow a very similar pattern to STX at the beginning of 2019.

If this week provides the read out that we are all expecting due to company guidance then it should be pivotal to the future of this company and further derisk its prospects.

Correct, can’t buy any stock!

Currently on 12 hours of solid research in last 2 days. Listening to podcasts, company presentation, just spent a couple of hours reading the last 12 months of posts on LSE and AD*VFN.

Very impressed and loving the research. Thank you.

Brooko, those are some serious trades. And will explain the difficulty in buying large numbers at times today.

I am new to this after watching for a while but the risk v reward over the medium term is very compelling.

Does anyone know what level of revenue each machine is expected to achieve per calendar year following FDA approval?

Thanks in advance

I have just been on the teleconference. I am sure that he just said that it is unlikely that Guyana will be drilled this year as they need time to input all data around the three wells. Can anyone confirm that?

Guidance as per Gil, Guyana forms part of the 2020 outlook and more importantly high grading of the Cretaceous prospects.

‘ The next phase of the review will focus on the investment plans for each of the Group's major assets.’

Gil says CPR expected by end of January and a meeting to take place between partners during January to discuss forward drilling plan and results to date.

It is also possible for partners of the block to drill in isolation of Tlw if they don’t have the budget or intention to drill this year.

And so we wait.

Is forming in the US on the intraday chart, would be nice to see it breakout to the upside in the last half hour.

Take pre and after hours market out of equation and the chart looks pretty attractive both here and across the pond especially. Imo

In all honesty given the cash position of the company and how the statistical data backs up the quality of the drug and its respective performance. As a proposition this has been massively de-risked.

This company is now a sitting duck for one of the big Pharma’s and partnering for some of the earlier stage assets is still on the table. Further results from MDi expected Q1 2020. Momentum is definitely back on side.

Looking at the cash balance, you can attribute about £50m for the IP, nuts. Cheap.

Interesting to see price is matching US after hours close. Wait for pre market to open in US and we should see this break 100p in UK. Their is a reason why the UK listed companies want to dual list in the US!

Goldandoil

‘Probably around 70p, then a slight increase up to 80p pr so, followed by the usual steady decline as those trapped last time (me!) bail out!’

I can’t work your agenda out. This is about to break 100p

It’s 92p in America after hours Friday before the good news was released. Good luck.

Wow, this is as good as it gets. If Carlsberg wrote RNS’s...

Given the size of the target market. I do not know of many companies with a market cap of £61m chasing such a prize. Could see a massive partnership with big Pharma with up front payment, milestones and royalties

Because when chasing investor relations last week due to a lack of response it was noted that key management were going to be at the conference.

By releasing this RNS late Friday it has drawn additional attention to the results Monday morning. A clever tactic which should only be adopted to exacerbate an increase but no a fall imo.

With top management at the JPM biotech meeting in America from tomorrow, it’s timing is indicative of good news. Imo bad news would of been saved for after the event.

Given the recent appointments and a new website. All points towards a positive, a positive the market was unlikely to attract much attention from the market late Friday night. When this has full market attention, expect fireworks.